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2 
Abstract  1 
 2 
Adequate iodine is important during pregnancy to ensure optimal growth and development of 3 
the offspring. This study aimed to develop and validate an iodine specific food frequency 4 
questionnaire (I-FFQ) for use in pregnant women. A 44-item I-FFQ was developed and 5 
administered to 122 pregnant women at study entry (<20 weeks gestation) and 28 weeks 6 
gestation. Iodine intake estimated from the I-FFQ was compared between the two time points 7 
for reproducibility. Correlation between iodine intake estimated from the I-FFQ and intake 8 
from a four day weighed food record, urinary iodine from a 24 hour and a spot urine sample, 9 
and thyroid function from a blood sample were assessed at 28 weeks gestation. Iodine intake 10 
from the I-FFQ at study entry and at 28 weeks gestation was strongly correlated (r=0.622, 11 
p<0.001). A moderate correlation was shown between intake from the I-FFQ and the four day 12 
weighed food record (r=0.349, p<0.001) which was strengthened with the addition of iodine 13 
supplements (r=0.876, p<0.001). There was a strong agreement (k=0.799, p<0.001) between 14 
the two dietary measures in the ability to classify the women as adequate (≥220µg/day) or 15 
inadequate (<220µg/day) intake but the limits of agreement from the Bland-Altman plot was 16 
low. Iodine intake from the I-FFQ correlated with 24 hour urinary iodine excretion (r=0.488, 17 
p<0.001) but did not correlate with spot urinary iodine concentration. In conclusion, the I-18 
FFQ provides a valid tool to estimate iodine intake in pregnant women and can be used to 19 




Iodine is crucial in the formation of thyroid hormones, triiodothyronine (T3) and thyroxine 23 
(T4), and is essential for mammalian life (1). Worldwide, iodine deficiency has emerged as a 24 
major public health issue because it is one of the most common micronutrient deficiencies, 25 
affecting developing as well as industrialised countries (2). This is of particular concern during 26 
pregnancy as iodine deficiency can lead to spontaneous abortion, premature births, impaired 27 
growth and adverse neurological development as well as cretinism and infant mortality in 28 
severe iodine deficiency (1, 3).   29 
Iodine requirement is thought to increase during pregnancy with the World Health 30 
Organisation (WHO) recommending that pregnant women increase their intake to 250µg/day 31 
compared with 150µg/day for women of child bearing age (2). This increased requirement is 32 
due to the transfer of thyroid hormone from the mother to the fetus as well as the greater renal 33 
clearance of iodine (4, 5). However, the recommended intake of iodine varies between 34 
industrialised countries, ranging from 140µg/day in the UK (no increment from non-pregnant 35 
women)(6) to 220µg/day in Australia, New Zealand and the United States (7, 8). Assessment of 36 
iodine intake is challenging as iodine content of foods is influenced by a number of factors 37 
including fertilisers, irrigation, sanitising and industrial agents, rainfall, season and location 38 
(9)
 and it is difficult to accurately estimate the intake of iodine from the use of iodised salt in 39 
cooking and at the table (10). As a result, urinary iodine concentration  is often used as an 40 
indicator of iodine status with the WHO/UNICEF/ICCIDD defining a median urinary iodine 41 
concentration of ≥150 µg/L, based on the recommended dietary intake, as sufficient iodine 42 
intake in pregnancy (11). However, UIC is reflective of recent iodine intake and has large 43 
intra-individual variation (12), limiting its use as an assessment of usual dietary iodine intake. 44 
Given the importance of iodine during pregnancy, an accurate assessment of habitual iodine 45 
intake is needed.  46 
Dietary assessment poses challenges as many tools rely on memory, accurate estimation of 47 
intake and time commitment (13). Food frequency questionnaires (FFQs) are used to assess 48 
longer term habitual intake, which is useful for nutrients such as iodine that are less common 49 
in the food supply (13). FFQs are less time consuming, have a low burden on participants and 50 
lower cost compared with the more traditional dietary assessment method of weighed food 51 
records (13). However, FFQs must be appropriate for the population in question, considering 52 
usual foods and food patterns. It is known that during pregnancy eating habits often change, 53 
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which may be a reflection of dietary recommendations, avoidance of foods as well as 54 
pregnancy related sickness (14). Thus, the dietary assessment method must be tailored to suit 55 
this population.  56 
Previous studies have developed and validated general FFQs and these have been used to 57 
assess iodine intake in pregnancy (15, 16). However, general FFQs are often long and time 58 
consuming. Additionally, much of the information captured in a general FFQ would not be 59 
relevant when the focus is on iodine intake. We are interested in developing an iodine 60 
specific food frequency (I-FFQ) that can be used in large scale studies to assess iodine intake 61 
as well as a simple tool to identify women with inadequate intake and who may be at risk of 62 
iodine deficiency.  63 
To our knowledge there are only three published I-FFQs that have been developed and 64 
validated, two for use in non-pregnant adult women in Denmark (17) and the UK (18) and one 65 
for use in the elderly (19). These questionnaires were validated for use in those specific 66 
populations, reflecting the common food habits and practices of the population and thus 67 
limiting their use in pregnancy. The aim of this study was to develop an I-FFQ for use in 68 
pregnancy and assess its reproducibility and validity against iodine intake from a weighed 69 
food record; (2) urinary iodine from a 24 hour and a spot urine sample and (3) blood 70 
biomarkers of iodine status.  71 
Methods 72 
Subjects 73 
Participants were recruited from women who were participating in the Pregnancy Iodine and 74 
Neurodevelopment in Kids (the PINK study) in Adelaide, Australia. A total of 122 women 75 
from the Women’s and Children’s Hospital were recruited between August 2011-April 2012 76 
from the antenatal clinic at their first antenatal appointment. Eligible women were less than 77 
20 weeks gestation with no history of thyroid disease. Ethics approval was obtained from the 78 
Women’s and Children’s Health Network (WCHN) Human Research Ethics Committee and 79 
all women provided written informed consent.  80 
Development of the I-FFQ 81 
The I-FFQ was developed to determine the women’s average iodine intake over the past 82 
month. The food items were selected based on the most up to date Australian food 83 
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composition database that is based on analytical data, NUTTAB 2010 (20). For food items that 84 
were not listed in NUTTAB, the AUSNUT 2007 was used to supplement the list, which 85 
incorporates nutrient data from a range of sources including recipes, international food 86 
composition tables as well as calculated and imputed data (21).  87 
 88 
Foods were included in the I-FFQ if they had an iodine content of  ≥ 5% of the recommended 89 
dietary intake (RDI) per serve for Australian pregnant women (10µg/serve). Serving sizes 90 
were based on standard serves using the Australian Guide to Healthy Eating or food labels 91 
and were expressed as measurements (in grams) or convenient household units (cup/tsp 92 
/tbsp). There were some foods that fell just below the 5% RDI criteria per serve, however 93 
were included in the I-FFQ as these foods were considered common in the Australian diet, 94 
including noodles and pasta, rice, cheese, ice cream, cooked broccoli, spinach and bok choy, 95 
chocolate, cashews, cheese flavoured snacks and pizza. For those food items with more than 96 
one variety, such as different types of fish and cheese, the average iodine content was used. 97 
The final questionnaire consisted of 44 food items (See appendix 1). The food items were 98 
classified into seven main food groups based on those listed in the NUTTAB database (20) 99 
including seafood, cereal products, dairy, egg, vegetables, snacks and sweets and ready made 100 
foods. For each food item, the frequency of intake was recorded as the number of serves per 101 
day, per week or per month. If the food was not consumed on a monthly basis the frequency 102 
of intake was marked as rarely/<1 per month.  An additional three questions were included 103 
which related to salt use, including whether salt was added in cooking or at the table, if the 104 
salt added was iodised salt and the individual daily portion used.   105 
 106 
Validation of the I-FFQ 107 
 108 
The validity of the I-FFQ was assessed in the following ways: 109 
1. The comparison of iodine intake estimated from the I-FFQ with the four day weighed 110 
food record at 28 weeks gestation. 111 
2. The reproducibility of the I-FFQ during pregnancy (<20 weeks and 28 weeks 112 
gestation). 113 
3. The correlation between iodine intake from the I-FFQ and urinary iodine from a 24 114 
hour urine sample and spot urine sample at 28 weeks gestation. 115 
4. The correlation between iodine intake and thyroid function (TSH, Tg, fT3 and fT4) at 116 
28 weeks gestation. 117 
6 
 118 
Assessment of iodine intake  119 
The women completed the I-FFQ at enrolment (<20 weeks gestation) and at 28 weeks 120 
gestation.  The questionnaire was checked for completeness by a dietitian.  To calculate the 121 
mean daily iodine intake, all frequencies of consumption (per week and per month) were 122 
converted to per day assuming that there were sever days in a week and 30 days in a month. 123 
The frequency of consumption per day was multiplied by the average iodine content of the 124 
specific food. This calculation was completed for each individual food item and was added 125 
together to give the total mean daily iodine intake. The use of iodised salt was not quantified 126 
and therefore not included in the total iodine intake.  127 
 128 
Women were asked to keep a weighed food record for four consecutive days including one 129 
weekend day between 26-28 weeks gestation. They were given oral and written instructions 130 
and were provided with digital kitchen scales and measuring cups. The women were asked to 131 
weigh and record details of the food consumed as well as weigh and record any left overs of 132 
each food item. If eating out the women were asked to record details about their meal. A 133 
separate space was provided to record any home cooked recipes including the amount (in 134 
grams or units) of raw ingredients used, the number of serves the recipe yields and the 135 
number of serves consumed. Foodworks with the NUTTAB 2010 and AUSNUT 2007 136 
(Version 7, 2012) was used to assess dietary intake from the weighed food records. Food 137 
items not listed in the database were entered as the closest resembling food item or the 138 
nutritional information derived from the food label or company website was added to the 139 
database. These food items were kept in a log for consistency of data entry.  140 
 141 
Information regarding supplement usage, including brand name, dose and frequency was 142 
gathered from women at 28 weeks gestation. Iodine intake from these supplements was 143 
calculated based on the manufacturer’s information and this was added to the iodine amount 144 
estimated from the I-FFQs and weighed food records as the total iodine intake.  145 
 146 
Assessment of urinary iodine  147 
Urinary iodine excretion from 24 hour urine collections were used to validate the I-FFQ as 148 
urinary iodine is determined from a pooled 24 hour sample and therefore is seen to better 149 
reflect an individual’s iodine excretion when compared to a spot urine sample (22). The 150 
women were asked to collect the 24 hour urine sample after completing the weighed food 151 
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record and within two days of their 28 week gestation appointment. The first urine passed on 152 
the day of collection was not saved and was recorded as the start time and date of the 24 hour 153 
collection. All urine passed for the next 24 hours was collected. The last sample was 154 
collected 24 hours later from the start time and was recorded as the end time and date. 155 
Women were provided with written instructions and with the necessary equipment, including 156 
a 4L container to store the total urine collected and a 1L measuring jug to assist with 157 
collecting each sample, both of which had been tested and cleared for iodine contamination. 158 
 159 
Once completed, the samples were refrigerated and delivered to the laboratory at the 160 
Women’s and Children’s Hospital within two days of collection.  The total volume was 161 
measured and aliquots of 10ml were taken and stored at -200C for analysis. The method for 162 
the analysis of UIC was modified from the WHO ‘Method A’ procedure (2, 23), using 163 
ammonium persulfate digestion and microplate reading. The analytical value for the external 164 
iodine standard was 284.5 ± 12.2µg/L compared with the certified value of 304 ± 44µg/L.  165 
The percent relative standard deviation of the assay was 4.3%.  166 
 167 
As part of the PINK study participants also provided a spot urine sample at 28 weeks. Similar 168 
to the 24 hour urine sample, UIC from the spot urine sample was analysed and used as an 169 
additional reference measure.  170 
 171 
Blood Biomarkers 172 
At 28 weeks gestation a blood sample was taken via venepuncture for analysis of thyroid 173 
stimulating hormone (TSH), thyroglobulin (Tg), free T3 (fT3) and free T4 (fT4). The analysis 174 
was conducted by SA Pathology, a National Association of Testing Authorities (NATA) 175 
accredited diagnostic laboratory in Adelaide. TSH, fT3) and fT4 were determined using an 176 
ADVIA Centaur automatic chemiluminescence immunoassay (Siemens Healthcare 177 
Diagnostics, US). Tg was determined using the Immulite 2000 chemiluminescent 178 
immunometric assay (Siemens Healthcare Diagnostics, UK). The coefficients of variability 179 
for TSH, fT3, fT4 and Tg were 5%, 7%, 4.5% and 8%, respectively.  180 
 181 
Sample size and Statistics  182 
 183 
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At the time that the study was conducted there was limited data on total dietary iodine intake 184 
in pregnant women. Therefore, sample size calculations were based on iodine intake data 185 
from a previous iodine FFQ validation study in females of child bearing age (17). Assuming a 186 
median iodine intake of 115µg (17), we estimated that 84 women would be required to detect a 187 
minimum difference of 20µg (10% of the RDI) in reported iodine intake between the two 188 
dietary assessment methods with 90% power and a correlation of 0.5 (p<0.05). A difference 189 
of < 10% RDI was considered clinically insignificant. 190 
 191 
Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) 192 
V16.0.0 (SPSS Inc. Chicago IL, USA).  Results were reported as the mean ± SD for 193 
continuous variables and number and percentage for categorical variables. Paired t tests were 194 
conducted to compare mean iodine intakes between the I-FFQ and weighed food records as 195 
well as iodine intake from the I-FFQ between the two time points (<20 weeks vs 28 weeks 196 
gestation). Pearson’s correlation coefficient was used to determine the corelation between 197 
iodine intake from the I-FFQ and weighed food record (food only and food plus supplements) 198 
as well as the correlation in iodine intake estimated from the I-FFQ (food only) at the two 199 
time points. Agreement between the two dietary methods was assessed using the Bland–200 
Altman method. Limits of Agreement (LOA), defined as the mean difference ± 2 standard 201 
deviations between the methods were calculated (24). 202 
 203 
Iodine intake from the I-FFQ and weighed food record was also categorised into adequate 204 
(≥220µg/day) and inadequate (<220µg/day) based on the Australian RDI. Weighted kappa 205 
coefficient k was used to assess the agreement in the categorisation between both dietary 206 
assessment methods. The following guide was used to describe the strength of agreement: k 207 
<0.20 = poor agreement; k: 0.21-0.40 = fair agreement; k: 0.41-0.60 = moderate agreement; 208 
k: 0.61-0.80=good agreement; k: 0.81-1.0 = very good/strong agreement (25).  209 
 210 
Linear regression analysis was used to assess the relationship between the I-FFQ (food + 211 
supplements) and biomarkers including urinary iodine excretion (UIE), UIC and thyroid 212 
function as well as the relationship between UIE from the 24 hour urine sample and UIC 213 
from the spot urine sample, adjusted for potential confounding factors including BMI, age, 214 
gestational age, parity, smoking status and education. Subgroup analyses were conducted to 215 
compare iodine supplement vs. non-iodine supplement users and iodised salt vs. non-iodised 216 





One hundred and twenty-two women were recruited for the validation study and 96 women 221 
completed the study. Characteristics of the participants are shown in Table 1. These women 222 
were aged between 18-41 years with a gestational age at study entry between 11-19.5 weeks. 223 
Seventy five percent of women were taking iodine supplements and 44% were using iodised 224 
salt. Demographic characteristics of non-completers (n=26) compared to completers (n=96) 225 
did not differ (data not shown). Reasons for women not completing the study included lack of 226 
time (n=17), withdrawal from the PINK study (n=7), miscarriage (n=1) and illness (n=1).  227 
 228 
Iodine intake from the I-FFQ and four day weighed food record 229 
 230 
Mean iodine intakes from the I-FFQ and four day weighed food record were 144 ± 52 µg/d 231 
and 160 ± 54 µg/d, p< 0.001 (food only) and 281 ± 124 µg/d and 297 ± 124 µg/d, p< 0.001  232 
(food + supplement). As shown in Figure 1, a significant correlation was found between the 233 
estimated iodine intake from the I-FFQ and weighed food record (r=0.349, p<0.001) that was 234 
strengthened once supplements were added (r=0.876, p<0.001). The limits of agreement 235 
(LOA) for the Bland-Altman plot was between -102 and 134 µg across the range of iodine 236 
intake reported from food (Figure 2).  There was a strong agreement (k=0.799, p<0.001) 237 
between the two dietary measures in the ability to classify the women as adequate or 238 
inadequate intake based on RDI with  92% of women classified into a same category.  239 
 240 
Reproducibility of the I-FFQ in pregnancy  241 
 242 
There was no difference in the mean iodine intake estimated from the I-FFQ completed at 243 
enrolment (<20 weeks gestation) and at 28 weeks gestation (153 ± 70 µg/d vs. 144 ± 52 244 
µg/day respectively, p=0.338). A significant positive correlation (r=0.622, p<0.001) was 245 
shown in the estimated iodine intake from the I-FFQ completed at the two time points (Figure 246 
3).   247 
 248 
Correlation between iodine intake estimated from the I-FFQ and UIC 249 
 250 
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Median UIC (interquartile range) from the 24 hour urine sample and spot urine sample was 251 
178 (38-586) µg/L and 212 (7-881) µg/L, respectively. Urinary iodine excretion (UIE) from 252 
the 24 hour urine sample was 332 (49-799) µg/day, calculated using UIC from the 24 hour 253 
urine multiply by the total volume of 24 hour urine. The percent of women with UIC <150 254 
µg/L was 39%from the 24 hour urine sample and 37% from the spot urine sample. Iodine 255 
intake from the I-FFQ was positively correlated with iodine concentration from the 24 hour 256 
urine sample expressed either as UIC (µg/L) or UIE (µg/day), with adjustment for BMI, age, 257 
gestational age, parity, smoking status and education (r=0.321 and  r=0.448, p<0.001, 258 
respectively) or without adjustment (r=0.299 and  r=0.477, p<0.001). There was no 259 
correlation between iodine intake from the I-FFQ and the spot urine sample (Table 2) or 260 
between UIE (µg/day) from the 24 hour urine sample and UIC (µg/day) from the spot urine 261 
sample (r=0.112, p=0.281).  262 
 263 
Correlation between iodine intake from the I-FFQ and thyroid function 264 
 265 
No correlation was found between total iodine intake (food + supplement) from the I-FFQ 266 
and any markers of thyroid function including TSH, fT3, fT4 and Tg  with or without 267 
adjustment for BMI, age, gestational age, parity, smoking status and education (Table 2).  268 
 269 
Subgroup analysis 270 
There were no differences in iodine intake (food only) estimated from the I- FFQ and 271 
weighed food record between subgroups (iodine supplement vs. non-supplement users or 272 
iodised salt vs. non-iodised salt users).  273 
 274 
Iodine-supplement users showed a correlation between iodine intake from the I-FFQ and the 275 
weighed food record (food only) (r=0.721, p<0.001), and between iodine intake from I-FFQ 276 
and UIC (µg/L) (r=0.362, p=0.004) or UIE (µg/day) (r=0.313, p=0.008) from the 24 hour 277 
urine sample, while no correlation was shown in non-iodine supplement users.  278 
 279 
Non-iodised salt users also showed a positive correlation between the I-FFQ and weighed 280 
food record (r=0.576, p<0.001) and between iodine intake from I-FFQ and UIC (µg/L) from 281 
the 24 hour urine sample (r=0.491, p<0.001) while no correlation was observed in iodised salt 282 
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users. UIE (µg/day) from the 24 hour urine sample was positively correlated with the I-FFQ 283 
in both iodised salt (r=0.331, p=0.028) and non-salt users (r=0.605, p<0.001).  284 
 285 
With the exception of fT4 in non-iodine supplement users, no correlation was shown between 286 
the I-FFQ and UIC (µg/L) from spot urine samples or thyroid function in all subgroups (data 287 
not shown).  288 
 289 
Discussion 290 
To the best of our knowledge this is the first study to develop and validate an iodine specific 291 
FFQ for assessing iodine intake in pregnant women, using both dietary assessment and 292 
functional biomarkers. Our results suggest that the I-FFQ can be used as a valid tool in 293 
estimating iodine intake in pregnant women as the I-FFQ had a good correlation with the four 294 
day weighed food record and UIE from the 24 hour urine sample, and showed strong 295 
reproducibility. Additionally, our results suggest that the I-FFQ can be useful in screening 296 
women that may be at risk of inadequate dietary intake.  297 
 298 
Our results show that the correlation between the I-FFQ and weighed food record was 299 
strengthened once supplements were added which is likely a result of the increased range of 300 
iodine intake. The correlation coefficient in our study compared well with other iodine FFQ 301 
validity studies in adults with four day weighed food records (r ranging from 0.45 to 0.52) (17, 302 
18)
 and repeated 24 hour dietary recalls (r=0.377) (19). Other validation studies in pregnancy 303 
have assessed multiple nutrients including iodine, and not surprisingly the findings were 304 
inconsistent with energy adjusted correlation coefficients ranging from 0.4 to 0.66 between 305 
FFQ and four day weighed food records (15, 26) to -0.03 between FFQ and a 24 hour diet recall 306 
(14)
, which may be a reflection of the reference method and FFQ used, including the length  307 
and food items included. Other single nutrient validation studies reported similar correlations 308 
to our study including an iron specific checklist with diet history interview (r=0.69, iron from 309 
food and supplement) during pregnancy (27)  and a calcium specific FFQ with six day 310 
weighed food record in women of child bearing age (r=0.42) (28).   311 
 312 
Although correlation analysis is commonly used, this does not indicate the agreement 313 
between two methods. The Bland-Altman method is often viewed as the preferred technique 314 
to assess agreement and hence to determine validity of a new method (24). The results of this 315 
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study showed large Limits of Agreement, indicating low agreement between the I-FFQ and 316 
the four day weighed food record. Many dietary validation studies  have found similar results 317 
(14, 17-19, 27, 29, 30)
. This is likely to be a reflection of the differences between the dietary 318 
measures, as FFQs are commonly used to estimate longer term, habitual intake while diet 319 
records or 24 hour recalls estimate recent intake. It should therefore be questionned whether 320 
assessing agreement using the Bland-Altman method is appropriate for dietary validation 321 
studies as this technique was originally designed to compare similar methods (24).  322 
 323 
Our study is the only validation study which used both 24 hour urine and spot urine samples 324 
as reference markers to validate I-FFQ.  The correlation between iodine intake from the I-325 
FFQ and 24 hour UIE in our study is comparable to one (17) of the two validation studies that 326 
examined this relationship in non-pregnant women but in contrast to the other study (18), 327 
which showed no correlation between iodine intake from I-FFQ and 24 hour UIE.  This is 328 
perhaps not surprising because although a 24 hour sample is less variation when compared to 329 
a spot urine sample (22, 31), it is still subjected to day-to-day variation in iodine intake and 330 
therefore it is not a reliable marker of iodine status for individuals  Furthermore, there was no 331 
correction between the 24 hour UIE (µ/day) and the spot UIC, demonstrating that UIC from a 332 
spot urine sample is a poor indication  of iodine intake and status. UIC based on spot urine 333 
adjusted for creatinine (expressed as iodine to creatinine ratio) has been suggested as a more 334 
accurate measure of iodine excretion and better reflection of iodine intake than spot UIC 335 
alone (12, 19, 22, 31, 32).  However, it has been shown that 10 repeated spot urine samples are 336 
needed to assess individual iodine status(12), which is cumbersome and impractical similar to 337 
the 24 hour urine collection. Due to these limitations of UIC as a marker of individuals’ 338 
iodine status, a simple I-FFQ like the one developed in our study would be a better and 339 
practical tool to assess iodine intake and status in pregnant women. 340 
 341 
No relation between iodine intake from the I-FFQ and any of the blood biomarkers was 342 
shown. It is known that thyroid function is tightly regulated and adaptive mechanisms are in 343 
place to ensure that the functional needs are met, even in times of mild iodine deficiency (33).  344 
Therefore, it may be that changes in blood biomarkers as a result of inadequate iodine intake 345 
will only occur in severely deficient populations, which is not the case for this population, 346 
explaining the lack of correlation shown here. This may also be similar to other biomarkers of 347 
nutrient intake as single nutrient validation studies in pregnancy that have used blood 348 
biomarkers as reference measures also found no or very weak correlations with FFQs (27, 34).  349 
13 
Additionally, there are a number of modifications in the regulation of thyroid function that 350 
occur during normal pregnancy, with not all of these entirely well understood. These normal 351 
changes may also contribute to the lack of correlation with dietary iodine intake.  352 
 353 
Within this population there were a similar number of women who used iodised salt 354 
compared to those that did not. Interestingly, non-salt users showed a stronger correlation 355 
between the I-FFQ and both the weighed food record and UIE (µg/day), while iodised salt 356 
users showed no correlation. Although not statistically significant, the non-iodised salt users 357 
had a higher iodine intake of approximately 20µg (10% RDI). It may be a possibility that 358 
those women who add no salt to cooking or at the table are more health conscious and 359 
therefore include foods that are higher sources of iodine, resulting in stronger correlations 360 
between the I-FFQ and weighed food record. Furtermore, iodised salt was not quanitified 361 
from the I-FFQ which may explain the poor correlation between the I-FFQ and UIE in 362 
iodised salt users compared to non-iodised salt users. However these results should be 363 
interpreted with caution as this is a secondary analysis and the sample size within the 364 
subgroups may be inadequate.  365 
 366 
This study has a number of strengths. The most updated food composition data was used 367 
when estimating iodine intake from the two dietary measures, and the time allocated for the 368 
collection of the reference methods was well controlled and the sample size was adequate. 369 
Additionally, both subjective (the gold standard for dietary assessment) as well as objective 370 
measures were used to assess the validity of the I-FFQ. However, we did not include iodine 371 
intake from iodised salt due to the issues associated with quantifying this. As half of the 372 
women reported the use of iodised salt, this is likely to have increased the mean iodine intake 373 
and therefore effect the relationship between the iodine intake from the I-FFQ and reference 374 




The validity of the I-FFQ to estimate habitual iodine intake in Australian pregnant women 379 
has been demonstrated by strong correlations with four day weighed food records and 380 
moderate correlation with UIE from 24 hour urine samples as well as strong reproducibility. 381 
Furthermore, the results of our validation study indicate that the I-FFQ can be used as a 382 
simple clinical tool to screen pregnant women at risk of inadequate iodine intake. However 383 
14 
the I-FFQ has limited ability to predict thyroid function. This I-FFQ could be modified to 384 
assess iodine intake in other populations.  385 
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Table 1: Demographic characteristics of the study population 
 Participants 
(n=96) 
 Mean SD 
Agea (year) 31.5 5.1 
Gestational Agea (week)   15.3 2.3 
Weighta (kg)  70.1 16.1 
BMIa (kg /m2)  26.2 5.8 
Primiparousb  55% (53) 
Completed secondary educationb  85% (82) 
Currently smokingb   
Smoking 3 months prior to pregnancyb  
7% (7) 
13% (12) 
Taking iodine containing supplementsb  75% (72) 
Using iodised saltb  45% (43) 
 
BMI: Body mass index 
aData are Mean ± SD 




















I-FFQ: Iodine specific food frequency questionnaire 
B: coefficient   
SE: standard error of the coefficient 
UIC: urine iodine concentration 
FT3: Free Triiodothyronine 
FT4: Free thyroxin 
TSH: Thyroid stimulating hormone 
TG: thyroglobulin 





















 B SE P  B SE P 
Spot urine UIC  0.213 0.128 0.095  0.239 0.143 0.098 
FT3 -0.001 0.000 0.052  0.000 0.000 0.318 
FT4 -0.001 0.001 0.529  0.000 0.001 0.097 
TSH 0.000 0.001 0.900  0.000 0.001 0.798 
TG -0.005 0.011 0.691  -0.009 0.012 0.488 
20 
 
Figure Legends  
Figure 1: Iodine intakes (µg/day) measured from the I-FFQ at baseline (<20 weeks) and 28 
weeks gestation (r=0.622, p<0.001).  
Figure 2: Iodine intakes (µg/day) measured from the I-FFQ and weighed food diary with a) 
no added supplements (r=0.349, p<0.001) and b) added supplements (r=0.876, p<0.001).  
Figure 3: Agreement between the I-FFQ and weighed food diary (µg/day) in estimates of 
iodine intake assessed by the Bland-Altman technique- mean difference (±2SDs) 
